Study Stopped
Enrollment not sufficient for data analysis.
SIS Evaluation of the MRI Defined Subthalamic Nucleus*
STN
Retrospective Multi-Site Re-Evaluation of the MRI Defined STN and Its Correlation to Motor Outcomes With Stimulation Treatment
1 other identifier
observational
15
1 country
1
Brief Summary
Retrospective review of images used to target the STN during DBS procedure and ability of the Surgical Information Sciences ("SIS") system to visualize the STN location.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2019
CompletedFirst Posted
Study publicly available on registry
April 8, 2019
CompletedStudy Start
First participant enrolled
June 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 11, 2022
CompletedApril 19, 2022
April 1, 2022
1.3 years
April 2, 2019
April 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percent of STN Visualization Success
Measure the proportion of images successfully processed for visualization of the STN over total number of image sets
Day 1
Incidence of DBS Lead Location in Proximity to STN
Determine incidence in which the location of the DBS lead is in or outside the STN
Day 1
Secondary Outcomes (2)
Rate of Correlation of Predicted Outcome to Monopolar Review Outcome
1 Month
Rate of Correlation of DBS Lead Location to Long Term Outcomes
3-6 months
Interventions
Software technology for visualization of anatomical structures in the brain
Eligibility Criteria
Subjects who have completed bilateral or unilateral high frequency stimulation of the subthalamic nucleus (STN-HFS) for idiopathic PD and have pre and post operative MR and CT imaging, programming data, Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) scores and a 3-6 month follow-up evaluation
You may qualify if:
- Idiopathic PD
- Bilateral or unilateral STN-HFS for PD
- % improvement response to medications preoperatively
You may not qualify if:
- Missing required MR/CT imaging data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPMC
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Noam Harel, PhD
Surgical Information Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2019
First Posted
April 8, 2019
Study Start
June 7, 2019
Primary Completion
September 30, 2020
Study Completion
April 11, 2022
Last Updated
April 19, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share